AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

EMINENCE MINERALS LTD

0.053

-0.009-14.52%

Volume:212.94K

Turnover:11.96K

Market Cap:8.25M

PE:-2.15

High:0.059

Open:0.059

Low:0.053

Close:0.062

52wk High:0.145

52wk Low:0.053

Shares:155.63M

Float Shares:82.24M

Volume Ratio:3.38

T/O Rate:0.26%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.025

EPS(LYR):-0.025

ROE:-16.77%

ROA:-9.84%

PB:0.44

PE(LYR):-2.15

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Neuren's Regulatory Hurdles for Trofinetide May Push Back EU Royalties, Says Jefferies

MT Newswires Live

Dogecoin Death Cross Countdown: Why This Chart Pattern Is Red Flag for DOGE Price

Nanoscope Secures Japan MHLW Sakigake and Orphan Drug Designations Across Inherited Retinal Diseases - A First for a Retinal Gene Therapy

BRIEF-Eminence Minerals Appoints Chief Executive Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/EMA.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EMA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EMA.AU\",,,,,undefined,":{"symbol":"EMA.AU","market":"AU","secType":"STK","nameCN":"EMINENCE MINERALS LTD","latestPrice":0.053,"timestamp":1770700320000,"preClose":0.062,"halted":0,"volume":212940,"delay":0,"changeRate":-0.14516129032258066,"nameEN":"EMINENCE MINERALS LTD","floatShares":82243410,"shares":155628951,"eps":-0.0246,"marketStatus":"Not Yet Opened","change":-0.009,"latestTime":"02-10 16:12:00 AEDT","open":0.059,"high":0.059,"low":0.053,"amount":11955,"amplitude":0.096774,"askPrice":0.06,"askSize":150000,"bidPrice":0.054,"bidSize":100000,"shortable":3,"etf":0,"ttmEps":-0.0246,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.062,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":3.376538,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EMA.AU\",,,,,undefined,":{"symbol":"EMA.AU","floatShares":82243410,"roa":"-9.84%","roe":"-16.77%","lyrEps":-0.0246,"volumeRatio":3.376538,"shares":155628951,"dividePrice":0,"high":0.059,"amplitude":0.096774,"preClose":0.062,"low":0.053,"week52Low":0.053,"pbRate":"0.44","psRate":"181.09","week52High":0.145,"institutionHeld":0,"latestPrice":0.053,"committee":-0.2,"eps":-0.0246,"divideRate":0,"volume":212940,"delay":0,"ttmEps":-0.0246,"open":0.059,"prevYearClose":0.066,"prevWeekClose":0.064,"prevMonthClose":0.06,"prevQuarterClose":0.066,"fiveDayClose":0.058,"twentyDayClose":0.066,"sixtyDayClose":0.086},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EMA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EMA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EMA.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609384536","title":"Neuren's Regulatory Hurdles for Trofinetide May Push Back EU Royalties, Says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2609384536","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609384536?lang=en_us&edition=fundamental","pubTime":"2026-02-06 08:13","pubTimestamp":1770336816,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals  facing regulatory uncertainty in the European Union  for its investigational drug trofinetide to treat Rett syndrome may delay royalties from sales in the region, Jefferies said in a note on Thursday.The European Medicines Agency  Committee for Medicinal Products for Human Use  gave a negative trend vote this week on the drug candidate's market authorization application, possibly due to concerns about the effect size in the confirmatory trial.Jefferies said the negative trend vote is an early indication that the regulatory authority might issue a negative opinion on the application at the final vote.The investment firm now expects royalties from EU sales of trofinetide to kick in the fourth quarter of fiscal 2026, and not second quarter.Meanwhile, it projects Neuren's experimental drug NNZ-2591 for treating Pitt-Hopkins Syndrome, a rare neurodevelopmental disorder, will receive reimbursement approval in the US in fiscal 2029.Jefferies lowered the company's fisca","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMA.AU","BK4081","BK4087","EMA","NEU.AU","BK7096","BK7129","BK7508","CHMP","BK4156"],"gpt_icon":0},{"id":"2608567193","title":"Dogecoin Death Cross Countdown: Why This Chart Pattern Is Red Flag for DOGE Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2608567193","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608567193?lang=en_us&edition=fundamental","pubTime":"2026-02-03 14:18","pubTimestamp":1770099480,"startTime":"0","endTime":"0","summary":"Dogecoin's slow decline might be heading into technical trouble. As of this week,DOGE is trading at just over $0.107 - barely holding above the Oct. 10 dump level of $0.0995, when $40 billion at least","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/dogecoin-death-cross-countdown-why-this-chart-pattern-is-red-flag-for-doge-price","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/dogecoin-death-cross-countdown-why-this-chart-pattern-is-red-flag-for-doge-price","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["LU1064131342.USD","LU2048586759.USD","EMA","LU2211815571.USD","EMA.AU","GTLS","LU2249611893.SGD","LU2355687059.USD","BK4217","LU0823414478.USD","IE0031619046.USD","LU2264538146.SGD","SMA","DOGE.USD.HKCC","PEGI","BK7129","IE00BFMHRM44.USD","BK4161","IE00B19Z4B17.USD","IE00B66KJ199.SGD","LU1988902786.USD","BK4081","IE00B7SZL793.SGD"],"gpt_icon":0},{"id":"2605144430","title":"Nanoscope Secures Japan MHLW Sakigake and Orphan Drug Designations Across Inherited Retinal Diseases - A First for a Retinal Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2605144430","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605144430?lang=en_us&edition=fundamental","pubTime":"2026-01-21 06:00","pubTimestamp":1768946400,"startTime":"0","endTime":"0","summary":"Japan's Ministry of Health, Labour and Welfare  grants MCO-010 Sakigake  and Orphan Drug designations, enabling an accelerated regulatory pathway for patients with severe inherited retinal diseases. Enhances strong global regulatory momentum, including multiple FDA expedited programs and five EMA Orphan designations. FDA, EMA and PMDA conditionally approve the MOGENRY brand name. Strengthens global pre-commercialization readiness and reinforces leadership in optogenetic therapy. DALLAS, Jan. 21, 2026 /PRNewswire/ -- Nanoscope Therapeutics, Inc., a biotechnology company developing disease-agnostic therapies for vision loss caused by retinal degeneration, today announced that Japan's Ministry of Health, Labour and Welfare  has granted both Sakigake  and Orphan Drug designations to MCO-010, its lead optogenetic therapy for patients with severe vision loss from inherited retinal dystrophies . Approximately 50,000 patients in Japan are affected by IRDs.The MHLW decision builds on strong reg","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2718911/NSCOPE_nu_Horizontal_2Color_1200px_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2718911/NSCOPE_nu_Horizontal_2Color_1200px_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/nanoscope-secures-japan-mhlw-sakigake-and-orphan-drug-designations-across-inherited-retinal-diseases--a-first-for-a-retinal-gene-therapy-302665003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7129","EMA.AU","EMA","BK4081","BLA.AU"],"gpt_icon":0},{"id":"2604901274","title":"BRIEF-Eminence Minerals Appoints Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2604901274","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604901274?lang=en_us&edition=fundamental","pubTime":"2026-01-19 11:33","pubTimestamp":1768793631,"startTime":"0","endTime":"0","summary":"BRIEF-Eminence Minerals Appoints Chief Executive OfficerJan 19 (Reuters) - Eminence Minerals Ltd EMA.AX:EMINENCE APPOINTS CHIEF EXECUTIVE OFFICERAPPOINTS ANTHONY HILLS AS CEOFurther company coverage: EMA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nTUE924ZBT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7129","EMA.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EMA.AU\",params:#limit:6,delay:true,,,undefined,":[]}}